Blue Jet Healthcare balance sheet

As of Mar 2025

Total assets: ₹1,418cr+33.9% on Mar 2024
Cash and investments: ₹220cr−20.5% on Mar 2024

₹ crore except per share

Tap a line for its trend	FY25Mar 2025	FY24Mar 2024

Non-current assets
	260	149
	88.9	147
	0.2	0.2
	0.3	—
	0.0	15.0
	5.5	4.9
	5.5	19.9
	16.6	14.3
	412	353
Current assets
	264	130
	187	235
	350	177
	33.0	41.0
	77.3	61.2
	1,006	706
	1,418	1,059
Equity
	34.7	34.7
	1,098	811
Liabilities
	4.7	4.1
	7.3	3.2
	1,162	853
	89.1	30.3
	1.3	1.1
	132	124
	1.9	2.8
	256	206
	1,418	1,059

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BLUEJET₹517.85

Blue Jet Healthcare Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB AARTIPHARM CAPLIPOINT ACUTAAS CONCORDBIO EMCURE ERIS GRANULES

View

In ₹ Crore except Per Share As of	FY24 31/03/2024	FY25 31/03/2025	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	149.1	259.6	259.6
+ Capital Work-in-Progress	147.1	88.9	88.9
+ Other Intangibles	0.2	0.2	0.2
+ Intangibles under Development	—	0.3	0.3
+ Non-current Investments	15.0	0.0	0.0
+ Other Non-current Financial Assets	4.9	5.5	5.5
Non-current Financial Assets	19.9	5.5	5.5
+ Other Non-current Assets	14.3	16.6	16.6
Total Non-current Assets	353.2	411.6	411.6
Current Assets
+ Inventories	129.8	263.9	263.9
+ Current Investments	235.5	186.7	186.7
+ Trade Receivables	176.9	349.5	349.5
+ Cash & Cash Equivalents	41.0	33.0	33.0
+ Other Current Assets	61.2	77.3	77.3
Total Current Assets	705.6	1,005.9	1,005.9
Total Assets	1,058.8	1,417.5	1,417.5
Equity
+ Equity Share Capital	34.7	34.7	34.7
+ Other Equity / Reserves	810.5	1,098.4	1,098.4
Liabilities
+ Provisions — Non-current	4.1	4.7	4.7
+ Deferred Tax Liabilities	3.2	7.3	7.3
Non-current Liabilities	852.9	1,161.6	1,161.6
+ Trade Payables	30.3	89.1	89.1
+ Provisions — Current	1.1	1.3	1.3
+ Current Tax Liabilities	124.1	131.8	131.8
+ Other Current Liabilities	2.8	1.9	1.9
Current Liabilities	206.0	255.9	255.9
Total Equity & Liabilities	1,058.8	1,417.5	1,417.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 97%.